Standard Diagnostics, Inc. Sustainability Profile
Standard Diagnostics, Inc., often referred to as Standardia, is a leading player in the in vitro diagnostics industry, headquartered in South Korea (KR). Founded in 2000, the company has established a strong presence in major operational regions across Asia, Europe, and North America. Specialising in the development and manufacturing of diagnostic kits, Standard Diagnostics offers a diverse range of products, including rapid tests and immunoassays, which are distinguished by their accuracy and reliability. The company has achieved significant milestones, including numerous certifications and partnerships that underscore its commitment to quality and innovation. With a robust market position, Standard Diagnostics is recognised for its contributions to healthcare, particularly in the fields of infectious diseases and chronic conditions. Its dedication to research and development continues to drive advancements in diagnostic solutions, making it a trusted name in the industry.
DitchCarbon Score
How does Standard Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Standard Diagnostics, Inc.'s score of 56 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Standard Diagnostics, Inc., headquartered in South Korea (KR), currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Abbott Laboratories, which may influence its climate commitments and reporting practices. While Standard Diagnostics, Inc. has not established its own reduction targets or climate pledges, it inherits sustainability initiatives from Abbott Laboratories. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are aimed at reducing greenhouse gas emissions across their operations. As a subsidiary, Standard Diagnostics, Inc. aligns with the broader climate strategies set forth by Abbott Laboratories, which may include ambitious targets for emissions reductions and sustainability practices. However, specific details regarding these targets or achievements are not available at this time. In summary, while Standard Diagnostics, Inc. does not provide its own emissions data or reduction targets, it is part of a corporate family that is actively engaged in climate initiatives through Abbott Laboratories.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 |
How Carbon Intensive is Standard Diagnostics, Inc.'s Industry?
How Carbon Intensive is Standard Diagnostics, Inc.'s Location?
Standard Diagnostics, Inc.'s Scope 3 Categories Breakdown
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Standard Diagnostics, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Standard Diagnostics, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.